Insights from 2023 SITC Annual Meeting
SITC 2023 Insights: "AI-Designed Personalized Neoantigen Vaccine, EVX-02, Induces Robust T-Cell Responses in Melanoma Patients"
Comments 0
Login to view comments.
Click here to Login